Das Tony
CIMA Vascular Group, Dallas, Texas 75231, USA.
Catheter Cardiovasc Interv. 2004 Sep;63(1):21-30. doi: 10.1002/ccd.20063.
Superficial femoral artery disease presents a complex challenge for therapy. The extent of vascular involvement may vary from focal disease with symptoms of intermittent claudication to long total occlusions manifest as critical limb ischemia. Optimal therapy requires understanding the available options including exercise programs, pharmacologic medical therapy, surgery and interventional endovascular therapy. Rapidly advancing endovascular technology for enabling safe intervention in complex, long occlusive segments of the superficial femoral artery continues to emerge. New devices like the SafeCross wire, Excimer laser, Silverhawk Atherectomy catheter, Cryoplasty catheter and new generations of bare metal and drug-eluting nitinol stents are shifting the paradigm for therapy from surgical to more endovascular treatment even for the most complex disease presentation.
股浅动脉疾病的治疗面临着复杂的挑战。血管受累程度可能各不相同,从伴有间歇性跛行症状的局灶性疾病到表现为严重肢体缺血的长段完全闭塞。最佳治疗需要了解包括运动计划、药物治疗、手术和介入性血管内治疗等可用选项。能够在股浅动脉复杂的长闭塞段进行安全干预的血管内技术正在迅速发展。诸如SafeCross导丝、准分子激光、Silverhawk旋切导管、冷冻球囊导管以及新一代裸金属和药物洗脱镍钛合金支架等新设备,正在使治疗模式从手术治疗转向更多的血管内治疗,即使是针对最复杂的疾病表现。